ArticlePDF Available

Beynen AC, 2019. Microalgae in petfood

Authors:

Abstract

Microalgae in petfood Microalgae are single-celled, aquatic organisms. They use sunlight or nutrient calories as energy source for growth and are cultivated in open-pond or closed-tank systems. Spirulina and chlorella, light-absorbing microalgae, can be found in supplements, treats and complete foods for dogs and cats. Alternatively, such products may contain a macronutrient-burning alga as source of DHA (docosahexaenoic acid). Spirulina in nutritional products for pets is often positioned as a superfood, thus appealing to nutrient-rich and health-giving. Superfood as qualification is redundant for spirulina in complete food, which by definition meets the target-animals' nutrient needs. That also holds for spirulina in a supplement or treat fed alongside complete food. Spirulina is frequently touted as immunity and skin supporter, but these and other health claims are unsubstantiated for dogs and cats. Marketed chlorella tablets and powders for dogs and cats assert to be nutritious, support immunity and detoxify the body. The first claim can be dismissed by grounds for redundancy and the second by lack of research evidence. Chlorella is believed to cleanse dog's and cat's body of accumulated, toxic chemicals coming from the environment, processed foods, preventive and therapeutic drugs (1-3). There is neither a theoretical nor experimental basis for ingested chlorella as detoxifier. Supplements, treats and complete foods featuring DHA-rich algae promise improvements in skin, coat and joint health, immunity, trainability of puppies and brain function of aged dogs. There is no evidence that extra intake of DHA, as sole omega-3, polyunsaturated fatty acid, meets the claims. Particularly, addition of algal DHA to the diet of older dogs did not convincingly enhance their performance in cognitive ability testing. Composition Dried algae, algal oil, algae meal and extract are listed in the European catalogue of feed materials (4). As a rough guide, autotrophic spirulina and chlorella contain 57% crude protein in the dry matter, 11% crude fat, 8 % ash, 6% crude fiber and 18% soluble carbohydrates (5-11). For the heterotrophic, DHA vehicle, Schizochytrium sp, the values are 11, 51, 9, 2 and 27% (12-15). Dried spirulina and chlorella reportedly hold about 1% chlorophyll and 0.1% carotenoids (6, 9), but there is a wide variation. Apart from chlorophyll, spirulina also has some 10% phycocyanin as photosynthetic pigment (6, 16). Dry spirulina contains about 2% GLA (gamma-linolenic acid), which is absent in chlorella, while both algae have negligible contents of EPA (eicosapentaenoic acid) and DHA (5, 9, 17). Dry, DHA-rich algae contain about 22% DHA, EPA making up less than 0.6% (12-15). The soluble polysaccharides in Spirulina platensis mainly comprise glucose and rhamnose (18), but there are species differences (19). Spirulina platensis and Chlorella pyrenoidosa have a high-molecular weight polysaccharide, comprising about 0.75% of microalgal dry weight, differing in glycosyl composition, but sharing high water solubility (20).
Creature Companion 2019; November: 40, 42.
Anton C. Beynen
Microalgae in petfood
Microalgae are single-celled, aquatic organisms. They use sunlight or nutrient calories as energy
source for growth and are cultivated in open-pond or closed-tank systems. Spirulina and chlorella,
light-absorbing microalgae, can be found in supplements, treats and complete foods for dogs and
cats. Alternatively, such products may contain a macronutrient-burning alga as source of DHA
(docosahexaenoic acid).
Spirulina in nutritional products for pets is often positioned as a superfood, thus appealing to
nutrient-rich and health-giving. Superfood as qualification is redundant for spirulina in complete
food, which by definition meets the target-animals’ nutrient needs. That also holds for spirulina in
a supplement or treat fed alongside complete food. Spirulina is frequently touted as immunity and
skin supporter, but these and other health claims are unsubstantiated for dogs and cats.
Marketed chlorella tablets and powders for dogs and cats assert to be nutritious, support
immunity and detoxify the body. The first claim can be dismissed by grounds for redundancy and
the second by lack of research evidence. Chlorella is believed to cleanse dog’s and cat’s body of
accumulated, toxic chemicals coming from the environment, processed foods, preventive and
therapeutic drugs (1-3). There is neither a theoretical nor experimental basis for ingested chlorella
as detoxifier.
Supplements, treats and complete foods featuring DHA-rich algae promise improvements in skin,
coat and joint health, immunity, trainability of puppies and brain function of aged dogs. There is
no evidence that extra intake of DHA, as sole omega-3, polyunsaturated fatty acid, meets the
claims. Particularly, addition of algal DHA to the diet of older dogs did not convincingly enhance
their performance in cognitive ability testing.
Composition
Dried algae, algal oil, algae meal and extract are listed in the European catalogue of feed materials
(4). As a rough guide, autotrophic spirulina and chlorella contain 57% crude protein in the dry
matter, 11% crude fat, 8 % ash, 6% crude fiber and 18% soluble carbohydrates (5-11). For the
heterotrophic, DHA vehicle, Schizochytrium sp, the values are 11, 51, 9, 2 and 27% (12-15).
Dried spirulina and chlorella reportedly hold about 1% chlorophyll and 0.1% carotenoids (6, 9), but
there is a wide variation. Apart from chlorophyll, spirulina also has some 10% phycocyanin as
photosynthetic pigment (6, 16). Dry spirulina contains about 2% GLA (gamma-linolenic acid), which is
absent in chlorella, while both algae have negligible contents of EPA (eicosapentaenoic acid) and
DHA (5, 9, 17). Dry, DHA-rich algae contain about 22% DHA, EPA making up less than 0.6% (12-15).
The soluble polysaccharides in Spirulina platensis mainly comprise glucose and rhamnose (18), but
there are species differences (19). Spirulina platensis and Chlorella pyrenoidosa have a high-
molecular weight polysaccharide, comprising about 0.75% of microalgal dry weight, differing in
glycosyl composition, but sharing high water solubility (20).
Spirulina
The large polysaccharide from Spirulina platensis activated cultured, human monocytes (20),
pointing to immunostimulatory capacity. Adding the polysaccharide to the diet of mice, or an algal
hot-water extract or phycocyanin to their drinking water, enhanced the production of
immunoglobulin A by Peyer’s patches ex vivo (21-23).
In the mouse studies, the administered amounts of spirulina components were equivalent to whole-
dried algae contents in dry food of 0.2-1.3% (Note 1). Four out of 10 complete, dry dog foods with
spirulina as ingredient, declare inclusion levels of 0.015-0.1%, while a cat food communicates 0.2%.
It is unknown whether the amounts of spirulina in commercial petfood, which presumably concern
dried, whole algae, promote immunity and visible health in dogs and cats.
The range of spirulina levels in commercial petfood might be appraised by a specific dog study.
Single gamma irradiation lowered white-blood cell counts in dogs. That effect was partly reversed by
feeding high-molecular weight polysaccharide from Spirulina platensis at a level equivalent to 0.08%
in dry food, but was unaffected by 0.02% (24). Those dietary concentrations correspond with 10.7
and 2.7% whole, dried spirulina.
Chlorella
Some petfoods have added chlorella. A complete, dry dog food declares an inclusion level of 0.2%. In
rodents, oral administration of a hot-water extract from Chlorella vulgaris augmented the resistance
against an intra-peritoneal infection with Escherichia coli or Listeria monocytogenes (25, 26). The
extract dosage was equivalent to 0.9 or 2.8% dried, whole chlorella in dry food (Note 2).
A small-scale, non-blinded, controlled study suggests that ingestion of chlorella powder may reduce
the severity of canine dermatitis (27). The chlorella dosage corresponded with 0.6% in dry food
(Note 3).
DHA-rich algae
Intake of fish oils, providing both EPA and DHA, may ameliorate atopic dermatitis (28) and
osteoarthritis (29-31), and modulate immunity indicators in dogs (32). There is no solid proof that
dietary DHA improves trainability of puppies (33). In aged dogs experienced on cognitive testing,
incorporation of 0.4% dried, whole-cell Schizochytrium sp into dry food inconclusively influenced the
outcomes of four different cognitive ability tests (14, Note 4). The control diet was DHA-free.
Inclusion of 0.4% of DHA-rich algae in dry food has been reported to increase apparent protein
digestibility and palatability in dogs (34), but confirmation is desirable. Oil from an undisclosed
species of Schizochytrium contains 40% DHA and 12% EPA. That algal oil, included at levels up to
2.9% in extruded dry food, was safe in a gestation-lactation-growth study in dogs (35). Its value as
functional ingredient is intriguing.
Note 1
In the mouse studies, the administered spirulina fractions contained the high-molecular-weight
polysaccharide (21), water-soluble substances (22) or phycocyanin (23). Immune effects of the
water-soluble substances (22) and phycocyanin (23) were determined in mice immunized by oral
administration of a crude shrimp extract or ovalbumin-entrapped microparticles. Immune
stimulation by the water-soluble fraction was much greater for lymphoid cells from spleen and
mesenteric lymph nodes than for those from Peyer’s patches (22).
The applied doses of the spirulina fractions can be converted into equivalents of dietary levels of
whole, dried spirulina. However, the microalga may also contain immunomodulatory components
other than those captured in the tested fractions. Dose dependency of the immune effects was not
addressed, implying that the calculated spirulina equivalents likely do not represent the lowest
effective dietary concentrations for mice. Compared with mice, dogs and cats may be more or less
sensitive to the spirulina fractions. Thus, the calculated dietary equivalents of whole spirulina only
provide a rough orientation towards the immunostimulatory impact of petfoods featuring the
microalga.
In one study (21), the high-molecular-weight polysaccharide fraction from spirulina was fed at a level
of 10 mg/mouse.day. That amount is equivalent to dry food containing 1.3% whole, dried spirulina.
The calculation is as follows: 10 (mg extract/mouse.day) x 100/15 (extract represented 15% of
whole, dried spirulina) x 1000/5 (dry food intake = 5 g/mouse.day) = 13333 mg/1000 g = 1.3 g/100 g.
Another feeding study with mice (22) used a hot-water extract of Spirulina platensis. The diluted
fraction was supplied in place of drinking water. The amount drunk was 3.4 ml/mouse.day, which is
equivalent to consumption of dry food containing 0.7% whole, dried spirulina. The calculation is as
follows: 3.4/60 (60-fold diluted extract) x 1000/1.55 (1000 mg dry spirulina matched 1.55 ml extract)
x 1000/5 (dry food intake = 5 g/mouse.day) = 7312 mg/1000 g = 0.7 g/100 g.
Phycocyanin was extracted from spray-dried Spirulina platensis, dissolved in water to a
concentration of 0.05% and given to mice as drinking water (23). The intake of phycocyanin was
equivalent to the feeding of a dry food containing 0.2% whole, dried spirulina. The calculation is as
follows: 0.5 (mg phycocyanin powder/ml) x 3 (fluid intake, 3 ml/mouse.day) x 80/100 (purity of
phycocyanin powder was 80%) x 100/10 (phycocyanin content of dry spirulina is 10%) x 1000/5 (dry
food intake = 5 g/mouse.day) = 2400 mg/1000 g = 0.2 g/100 g.
Note 2
Through stomach tube, mice and rats received daily, per kg body weight, 1000 mg lyophilized, hot-
water extract from Chlorella vulgaris (25, 26). The dry extract contained 39.5 g carbohydrates/100 g.
Thus, 1 g dry extract is equivalent to 2.2 g (39.5/18) whole, dried chlorella. It is assumed that a 20-g
mouse and 250-g rat consume 5 and 20 g dry food/day. The dosages in mice (20/1000 x 2.2 x 100/5)
and rats (250/1000 x 2.2 x 100/20) correspond with 0.88 and 2.75% whole, dried chlorella in dry
food.
Note 3
The dogs received 0.1 g chlorella powder per kg body weight (27). This amount corresponds with
0.6% in dry food, assuming an intake of 16.7 g dry food per kg body weight.
Note 4
Dogs fed a diet without or with 0.4% dried, whole-cell Schizochytrium sp were subjected to
assessment of cognitive function (14). After a wash-in period of 51 days, the two diet groups
underwent five tests over the next 124 days. The tests were as follows: a retest on delayed-non-
matching-to-position, (RDNMP), concurrent discrimination learning (CDL), contrast sensitivity
learning (CSL), variable contrast discrimination (VCD) and retention of concurrent discrimination
learning (RCDL). Each dietary group had 12 dogs aged 9-11 years.
All cognitive function tests use a food reward to motivate dogs to learn the tasks. The DNMP test
measures the ability to learn discriminating between different objects and their positions. The CDL
test addresses the dog’s ability to learn recognizing different pairs of objects. The CSL test was used
to measure contrast sensitivity as an index of visual processing ability. The dogs were tested at
progressively lower contrasts (CSL) or at variable contrasts (VCD).
The RDNMP test did not show a diet effect. Repeated measurements within the CDL tests produced
unsystematic diet differences for the dog’s responses. Two out of the 7 CDL sessions yielded a
significant diet effect, but the multiple comparisons were not taken into account by reducing the
preset P value. The RCDL test did not reveal a diet effect. The algal-fortified diet was found to reduce
the number of errors in the CSL test, but only after the removal of so-called non-responders. That
approach may have introduced selection bias, especially because it was unknown whether a
response or non-response was caused by random within-animal fluctuation or by true/repeatable
differences in responsiveness between individual animals. There was no convincing evidence for a
diet effect in the VCD test; there seemed to be diet effects at two intermediate contrast levels, but
not at the lower and three higher contrast levels.
Note 5
Analysed concentrations of heavy metals in spirulina products were low (36).
Note 6
In cats fed a high-cholesterol diet, administration of concentrated Spirulina plantensis by oral gavage
lowered serum cholesterol levels (37). The spirulina doses were 0.5 and 1.0 g/kg body weight.day.
Those doses would be 3.3 and 6.6% dried spirulina in dry food for a 4-kg cat consuming 60 g
food/day. In feline, bronchoalveolar lavage macrophages, a water-soluble extract from Spirulina
platensis enhanced phagocytic function (38).
Note 7
In dogs fed dry diets containing either 13% beef tallow or 13% of soybean oil plus DHA-rich algae,
oxidative stress markers were not different (39). The composition of the oil-algae mixture is
undisclosed. A communication in abstract form concludes that feeding unextracted
Aurantiochytrium limacinum microalgae for 15 days was without negative effects on health in
mature dogs (40). The dietary inclusion percentage is not reported. A paper suggests that dietary
DHA induces beneficial changes in the canine electroretinogram (41). The study was uncontrolled
and involved three dogs fed a diet containing 0.4% DHA-rich algae for 30 days.
Literature
1. Becker K. How to gently cleanse your pet’s body of toxins. Febuary 15, 2012.
https://healthypets.mercola.com/sites/healthypets/archive/2012/02/15/detox-for-pets.aspx
2. Chlorella algae for dogs. https://www.vettherm.de/VETtherm-dog/CHLORELLA-algae-for-dogs
3. Peralta J. Chlorella for dogs: help your dog detox with this green machine.
https://www.dogsnaturallymagazine.com/chlorella-for-dogs-help-your-dog-detox-with-this-green-
machine/
4. Commission Regulation (EU) 2017/1017 of 15 June 2017 amending Regulation (EU) No 68/2013 on
the Catalogue of feed materials. OJEO L 159/48 (21.6.2017).
5. Holman BWB, Malau-Aduli AEO. Spirulina as a livestock supplement and animal feed. J Anim
Physiol Anim Nutr 2013; 97: 615-623.
6. Happy Farm spirulina powder. http://www.happyfarm.co.th/16603454/spirulina-powder-feed-
animal-grade
7. Becker EW. Micro-algae as a source of protein. Biotechnol Adv 2007; 25: 207-210.
8. Barkia I, Saari N, Manning SR. Microalgae for high-value products towards human health and
nutrition. Marine Drugs 2019, 17, 304. doi:10.3390/md17050304
9. Kent M, Welladsen HM, Mangott A, Li Y. Nutritional evaluation of Australian microalgae as
potential human health supplements. PlosOne 10(2): e0118985. doi:10.1371/journal.pone.0118985
10. Lubitz JA. The protein quality, digestibility, and composition of algae, chlorella 71105. J Food Sci
1963; 28: 229-232.
11. Shalaby SM, Yasin NMN. Quality characteristics of croissant stuffed with imitation processed
cheese containing microalgae Chlorella vulgaris biomass. World J Dairy Food Sci 2013; 8: 58-66.
12. DHAgold® for companion animals. DHAgold® S17-B. DSM Nutritional Products.
https://www.dsm.com/content/dam/dsm/anh/en_US/documents/DHAgold_for_companion_animal
s.pdf
13. DHAgold®. Sustainable algae derived DHA omega-3 for companion animals. DSM Nutritional
Products Ltd, 2016. https://www.dsm.com/content/dam/dsm/anh/en_US/documents/DSM-
DHAGold-Brochure-EN.pdf
14. Hadley KB, Bauer J, Milgram NW. The oil-rich alga Schizochytrium sp. as a dietary source of
docosahexaenoic acid improves shape discrimination learning associated with visual processing in a
canine model of senescence. Prostaglandins Leukot Essent Fatty Acids 2017; 118: 10-18.
15. AlgaPrime® DHA. Corbion, 2019. http://algaprime.com/Algaprime_Product_Sheet.pdf
16. Seo YC, Choi WS, Park JH, Park JO, Jung K-H, Lee HY. Stable isolation of phycocyanin from
Spirulina platensis associated with high-pressure extraction process. Int J Mol Sci 2013; 14: 1778-
1787. doi:10.3390/ijms14011778
17. Ötles S, Pire R. Fatty acid composition of Chlorella and Spirulina microalgae species. J AOAC Int
2001; 84: 1708-1714.
18. Shekharam KM, Venkataraman LV, Salimath PV. Carbohydrate composition and characterization
of two unusual sugars from the blue green alga, Spirulina platensis. Phytochem 1987; 26: 2267-
2269.
19. Wang F, Ma Y, Liu Y, Cui Z, Ying X, Zhang F, Linhardt RJ. A simple strategy for the separation and
purification of water-soluble polysaccharides from the fresh Spirulina platensis. Sep Sci Technol
2016. http://dx.doi.org/10.1080/01496395.2016.1244549
20. Pugh N, Ross SA, ElSohly HN, ElSohly MA, Pasco DS. Isolation of three high molecular weight
polysaccharide preparations with potent immunostimulatory activity from Spirulina platensis,
Aphanizomenon flos-aquae and Chlorella pyrenoidosa. Planta Med 2001; 67: 737-742.
21. Balachandran P, Pugh ND, Ma G, Pasco DS. Toll-like receptor 2-dependent activation of
monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int
Immunopharmacol 2006; 6: 1808-1814.
22. Hayashi O, Hirahashi T, Katoh T, Miyajima H, Hirano T, Okuwaki Y. Class specific influence of
dietary Spirulina platensis on antibody production in mice. J Nutr Sci Vitaminol 1998; 44: 841-851.
23. Nemoto-Kawamura C, Hirahashi T, Nagai T, Yamada H, Katoh T, Hayashi O. Phycocyanin
enhances secretary IgA antibody response and suppresses allergic IgE antibody response in mice
immunized with antigen-entrapped biodegradable microparticles. J Nutr Sci Vitaminol 2004; 50: 129-
136.
24. Zhang H-Q, Lin A-P, Sun Y, Deng Y-M. Chemo- and radio-protective effects of polysaccharide of
Spirulina platensis on hemopoietic system of mice and dogs. Acta Pharmacol Sin 2001; 22: 1121-
1124.
25. Hasegawa T, Okuda M, Nomoto K, Yoshikai Y. Augmentation of the resistance against Listeria
monocytogenes by oral administration of a hot water extract of Chlorella vulgaris in mice.
Immunopharmacol Immunotoxicol 1994; 16: 191-202.
26. Hasegawa T, Tanaka K, Ueno K, Ueno S, Okuda M, Yoshikai Y, Nomoto K. Augmentation of the
resistance against Escherichia coli by oral administration of a hot water extract of Chlorella vulgaris
in rats. Int J Immunopharmacol 1989; 11: 971-976.
27. Maeda M, Kasuya Y, Yuasa K, Hiranaka T, Chubachi H, Saito M, Takegoshi H. The anti-
inflammatory activity of Chlorella in beagles with skin disorders. Proc Annual Meeting Japan Society
for Bioscience, Biotechnology and Agrochemistry, 2008.
28. Beynen AC. Vetzuurtherapie bij honden met atopische dermatitis. Dier-en-Arts 2017; Nr 8/9:
222-225.
29. Beynen AC. Visolie en behandeling van osteoartritis bij honden en katten. Dier-en-Arts 2016; Nr
10: 264-267.
30. Beynen AC. Fish oil in mobility foods for dogs. Creature Companion 2016; September: 52, 54.
DOI: 10.13140/RG.2.2.21423.74409
31. Beynen AC. Mobility dog foods are based on wobbly evidence. All About Feed 2017; 25/1: 42.
DOI:10.13140/RG.2.2.33874.56000
32. Wander RC, Hall JA, Gradin JL, Du SH, Jewell DE. The ratio of dietary (n-6) to (n-3) fatty acids
influences immune system function, eicosanoid metabolism, lipid peroxidation and vitamin E status
in dogs. J Nutr 1997; 127: 1198-2005.
33. Beynen AC. Brain food for puppies. Creature Companion 2017; January: 36, 38.
DOI: 10.13140/RG.2.2.35496.37126
34. Souza CMM. Microalgae Schizochytrium sp as a source of docosahexaenoic acid (DHA): Effects on
diet digestibility, oxidation and palatability and on immunity and inflammatory indexes in dogs. MSc
thesis, Federal University of Paraná, Curitiba, Brazil, 2018.
35. Dahms I, Bailey-Hall E, Sylvester E, Parenteau A, Yu S, Karagiannis A, Roos F, Wilson J. Safety of a
novel feed ingredient, algal oil containing EPA and DHA, in a gestation-lactation-growth feeding
study in Beagle dogs. Plos One 2019; 14: e0217794. https://doi.org/10.1371/journal.pone.0217794
36. Al-Dhabi NA. Heavy metal analysis in commercial Spirulina products for human consumption.
Saudi J Biol Sci 2013; 20: 383-388.
37. Shamsudin L, Ab Rashid S, Rozaini NNM, Kyaw T. Cyanobacterium Spirulina platensis LUQS1:
Effects on serum lipids and kidney in domestic cats, Felis catus. Malaysian J Microbiol 2018; 14: 265-
271.
38. Qureshi MA, Ali RA. Spirulina platensis exposure enhances macrophage phagocytic function in
cats. Immunopharmacol Immunotoxicol 1996; 18: 457-463.
39. Pacheco GFE. Supplementation of antioxidant based on algae in diets for dogs containing high
levels of saturated or insaturated fatty acids. DVM thesis, Federal University of Rio Grande do Sul,
Porto Alegre, Brazil, 2018.
40. Moran C, Reinemeyer C, Keegan J, Groenewegen P, Jacques K. A crossover target animal safety
study of unextracted Aurantiochytrium microalgal biomass (AURA) as a dietary source of
docasahexaenoic acid in mature dogs. J Anim Sci 2018; 96 (Suppl S3): 156.
41. Risolia DW, Menezes CMM, Lima DC, Santos AAM, Montiani-Ferreira F, Félix AP.
Supplementation in the diet of adult dogs with docosahexaenoic acid (DHA) from the microalgae
Schizochytrium sp. and evaluation of their effects on the retina. Arch Vet Sci 2018; 23: 19-20.
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
An Algal Oil Containing EPA and DHA (AOCED) at ~50% was developed as a sustainable source of omega-3 fatty acids. AOCED was incorporated into extruded dry foods for dogs at 0, 0.75%, 1.5% and 3.0% levels (equivalent to 0, 7.5, 15 and 30 g/kg diet) on dry matter basis at the expense of chicken fat and fed to healthy female Beagle dogs starting at mating and throughout gestation and lactation. The offspring were fed their maternal corresponding diets for 26 weeks after weaning. AOCED-enriched diets were well tolerated by dogs in both generations and did not affect their overall health, physiological parameters, food consumption, body weights and body weight gains. There were no changes in hematology, clinical chemistry, and coagulation parameters in both generations of dogs fed the AOCED diets when compared to those in the control group. Plasma levels of DHA and EPA increased significantly and generally dose-dependently in both generations. The study demonstrated the safety of AOCED in dogs during gestation, lactation, and growth periods at dietary levels up to 3.0wt%, equivalent to 30 g/kg diet. AOCED’s bioavailability as a source of DHA and EPA in dogs was demonstrated by the increased plasma concentrations of these nutritional lipids.
Article
Full-text available
Microalgae represent a potential source of renewable nutrition and there is growing interest in algae-based dietary supplements in the form of whole biomass, e.g., Chlorella and Arthrospira, or purified extracts containing omega-3 fatty acids and carotenoids. The commercial production of bioactive compounds from microalgae is currently challenged by the biorefinery process. This review focuses on the biochemical composition of microalgae, the complexities of mass cultivation, as well as potential therapeutic applications. The advantages of open and closed growth systems are discussed, including common problems encountered with large-scale growth systems. Several methods are used for the purification and isolation of bioactive compounds, and many products from microalgae have shown potential as antioxidants and treatments for hypertension, among other health conditions. However, there are many unknown algal metabolites and potential impurities that could cause harm, so more research is needed to characterize strains of interest, improve overall operation, and generate safe, functional products.
Article
Full-text available
Abstract Microalgae are able to enhance the nutritional content of conventional foods and hence to positively affect human health, due to their original chemical composition. The aim of the present study was to prepare fresh croissant filled with imitation cheese enriched with different amounts of Chlorella vulgaris biomass and to assay the quality parameters of the resulted croissant. Chemical composition of algal biomass, imitation cheese and croissant, as well as texture of cheese, staling rate, yeasts and moulds counts and sensory evaluation of resulted croissants were determined. The incorporation of microalgae resulted in an increase of quality parameters of croissant treatments when compared to the control sample. The chemical composition and staling rate of croissant remained relatively stable with the addition of cheese enhanced with microalgae. Results from sensory analysis of croissants filled with imitation cheese enhanced with different quantity of Chlorella vulgaris biomass showed that the using of this microalga in imitation cheese improved the sensory quality characteristics of croissants. Use of 2 and 3 % of the microalgae significantly (P ≤ 0.05) impact on better croissants taste, texture and eating quality. The results obtained are in accordance with the aim of this work to develop innovative croissant that are attractive to consumers with similar texture and flavor profiles to those of the traditional common croissant.
Research
Full-text available
Mobility dog foods are based on wobbly evidence Mobility impairment due to osteoarthritis is a common canine disease. Affected dogs are reluctant to walk and may show symptoms of chronic pain and lameness. Osteoarthritis is a degenerative and inflammatory condition caused by degradation of cartilage matrix in joints. The marketplace offers a wide variety of mobility dog foods claiming to support joint health. Veterinary mobility foods are indicated for treatment of canine osteoarthritis. The mobility claims are linked to supplements (functional ingredients) from a pool of some 13 ostensible candidates. Effective supplements provoke better joint function in dogs than a placebo as substantiated by meaningful, statistically significant and reproducible effects. So far, efficacy evaluation comprised treatment rather than prevention of osteoarthritis. Clinical trials must be double-masked to neutralize the generally observed placebo effect in dogs with osteoarthritis. The most commonly used additions, glucosamine and chondroitin sulfate, were ineffective in four out of five double-blinded, placebo-controlled trials in osteoarthritic dogs (1-5). In four such trials, greenlipped mussel had no or meaningless effect (1, 6-8). Curcumin showed unconvincing efficacy in one study (9). Boswellia resin was only tested in an open, non-controlled trial (10). Green tea alone, methyl sulfonyl methane, devil's claw, mulberry and grape extracts are untested in dogs. Four randomized, double-blind, placebo-controlled trials have assessed the impact of dietary fish oil on the severity of clinical signs in osteoarthritic dogs (11-14). On a 0-10 scale, the mean placebo-corrected improvements were 0.1, 0.4, 0.8 and 4.2 units so that clinical relevance is open to dispute. Gelatin hydrolysate and beta-1,3/1,6-glucans had positive effects of 1.3 and 0.5 units (15, 16), but reproducibility is unknown. The three substances likely have different mechanisms of action, implying that the combination works synergistically, but this remains to be demonstrated. Fish oil, gelatin hydrolysate and beta-1,3/1,6-glucans each showed a small, positive effect on osteoarthritic signs. Does the effect size seen experimentally extend to that of mobility foods carrying the ingredients concerned? In other words, are preparation and dosing identical for trial and food, and does functionality survive petfood processing? These questions may be answered by the petfood manufacturer. Literature 1. Dobenecker B, Beetz Y, Kienzle E. A placebo-controlled double-blind study on the effect of nutraceuticals (chondoitin sulfate and mussel extract) in dogs with joint disease as perceived by their owners. J Nutr 2002; 132: 1690S-1691S. 2. Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec 2003; 152: 323-329.
Article
Full-text available
Whole cell Schizochytrium sp. is a rich source of omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) including docosahexaenoic acid (DHA), an important nutrient for brain health. Aged beagle dogs experienced on a visuospatial task of working memory, variable-delay delayed-non-matching-to-position were used to assess efficacy of DHA-rich microalgae based upon DHA wt% of total phospholipids and 8-iso-PGF2α concentrations in plasma, and performance on cognitive assessments of visual object discrimination, learning, and memory consolidation after 25 weeks on fortified diet. Improved DHA status (p<0.001) and initial learning of the protocols for visual and variable contrast discrimination (p<0.05), but not long-term recall of the concurrent discrimination task were observed in animals fed the algal-fortified diet. Overall, results were consistent with dried Schizochytrium sp. as a source of n-3 LCPUFA nutrition to support DHA status in large mammals, and healthy brain function in a canine model of senescence.
Research
Full-text available
Puppy training is important for successful socialization and owner interaction. Teaching complex tasks concern future sporting, hunting, police or service dogs. Many new puppy owners turn to veterinary practices or obedience schools for advice and assistance. These same people may be taken by foods that claim to support healthy brain and make puppies smarter and more trainable. Such puppy foods feature omega-3 DHA (docosahexaenoic acid) for strong brain development. Newborn puppies have only 10 % of their adult brain mass and considerable growth occurs during the first three months of life. DHA is a key building block for neural tissues and undoubtedly is important in brain function. Puppy foods for brain health highlight DHA, but nutrition is not the only source of brain DHA. The brain can produce DHA from ALA (alpha-linolenic acid), EPA (eicosapentaenoic acid) and DPA (docosapentaenoic acid) or take up blood DHA synthesized in other tissues. Dry foods claiming to bring about DHA-mediated improvement of a puppy's learning ability contain around 0.14% DHA. The function claim is not convincingly supported by published research data. DHA was not the only dietary variable or not reported as such. Taken together the testing of three research groups, increasing dietary DHA, from 0.02% or less to 0.14% or more, was associated with lack of benefit in 7 out of 13 learning and memory tasks. Trainability relates to puppy's ability to understand what the owner or caregiver wants, willingness to learn and remembering the tasks being taught. Nutrient-deficient diets may disrupt trainable performance, but for a puppy fed a regular, nutrient-adequate, commercial food, its intelligence and the method of training determine success. DHA requirement The dietary amount of DHA needed for growth of young dogs has not been determined experimentally. This also applies to the other omega-3 fatty acids, ALA and EPA. The adequate intakes are based on canine milk composition and an arbitrary multiplying factor (1). The recommended total amount of DHA plus EPA is 0.05% in the dietary dry matter. The minimum requirement of ALA equals 0.08% at 1.3% linoleic acid (LA). The high concentrations of DHA in the brain and retinas point at a functional role in these tissues. As happens with rat pups, omega-3 fatty acid deficiency may cause subnormal growth and impaired cognitive and visual development in juvenile dogs. In puppies that had been exposed during gestation, lactation and weaning to a dry diet that approximates omega-3 requirements (ALA-EPA-DHA-LA = 0.14-0.02-0.02-1.75%), electroretinographic abnormalities were not detected (2). Extra DHA pre-and post-weaning Kelley et al. (3-9) have reported on learning ability in puppies born to bitches fed diets containing different amounts of DHA during gestation and lactation and weaned to the same diets. The diets,
Article
Full-text available
A novel and industrially applicable strategy for separating and purifying the water-soluble polysaccharides from the fresh Spirulina platensis is introduced in this study. After hot water extraction, using chitosan flocculation treatment, 86.0 % of the particles and 85.9 % of the pigments in the crude extract were removed. The purity of polysaccharides could be increased to 94.6 % and 96.1 % by applying the maroporous resin ADS-7 to remove the impurities in the mode of static adsorption and in a dynamic mode of operation, respectively. The polysaccharides obtained were composed of three major components having molecular weights of 1400, 420 and 2 kDa.
Research
Full-text available
Fish oil in mobility foods for dogs Dogs afflicted by degenerative joint disease move slower and have trouble when getting up from a lying position. The pain prompts the dog to diminish use of the joint. Motion becomes more and more restricted and lameness may develop. Most of the dogs concerned are older and suffer from so-called osteoarthritis. Sham treatment of canine osteoarthritis generally leads to improvement as perceived by owners and investigators. This placebo effect may be caused by positive expectancy and/or spontaneous course of the disease. Bias is excluded when assessors do not know which dogs are receiving real or placebo treatment. Double-blinded, placebo-controlled trials are considered the gold standard in clinical studies. If an intervention induces greater improvement than placebo treatment it is truly effective. Marine fish oils are rich in the omega-3 fatty acids named eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Model studies suggest that EPA and DHA suppress both inflammation-induced pain and degeneration of joint cartilage. Thus, the two omega-3s might fight osteoarthritis. Proof of efficacy must come from well-designed trials in dogs with osteoarthritis. In its simplest design, a double-blinded, placebo-controlled trial involves forming of two groups of osteoarthritic dogs, assessing baseline severity of disease status, administering an intervention or placebo treatment to the groups and collecting follow-up assessment. The changes over time in joint impairment are compared to see if the reduction in pre-existing severity of osteoarthritis differs between actively-treated dogs and placebo controls. The overall results of five studies indicate that fish oil consumption has very weak impact in dogs with naturally occurring osteoarthritis. Fish oil supplements In 1992, Miller et al. (1) published a non-blinded, non-controlled study on oral administration of capsules containing a variety of fatty acids, including EPA, to 22 dogs with symptomatic pelvic arthritis. The authors suggested tentatively that the improvement in symptoms seen in six excellent responders was due to the supplement. Twenty years after the open study, Hielm-Björkman et al. (2) reported their randomized, double-blinded, placebo-controlled study on fish oil supplementation. The study (2) comprised of osteoarthritic dogs receiving either fish oil (n = 35) or corn oil with fish smell (n = 36) for 16 weeks. A 30-kg test dog consumed 0.42 g EPA and 0.09 g DHA per MJ of metabolizable energy. Owners quantified their dogs' lameness on a 10-cm line (0 cm = no lameness; 10 cm = worse possible). Group-mean changes were-0.5 and-0.3 cm for control and test dogs. The minus sign represents a decrease in severity. Veterinarians assessed mobility on a 0-12 scale (0 = no difficulty) and noted changes of +0.2 and-0.3.
Article
Full-text available
This study investigated the biochemical suitability of Australian native microalgal species Scenedesmus sp., Nannochloropsis sp., Dunaliella sp., and a chlorophytic polyculture as nutritional supplements for human health. The four microalgal cultures were harvested during exponential growth, lyophilized, and analysed for proximate composition (moisture, ash, lipid, carbohydrates, and protein), pigments, and amino acid and fatty acid profiles. The resulting nutritional value, based on biochemical composition, was compared to commercial Spirulina and Chlorella products. The Australian native microalgae exhibited similar, and in several cases superior, organic nutritional properties relative to the assessed commercial products, with biochemical profiles rich in high-quality protein, nutritious polyunsaturated fats (such as α-linolenic acid, arachidonic acid, and eicosapentaenoic acid), and antioxidant pigments. These findings indicate that the microalgae assessed have great potential as multi-nutrient human health supplements.
Article
Aims: Researchers found a wide range of therapeutic properties in Spirulina sp. including as anti-cholesterol or antihyperlipidemic agent. In this study, the lipid levels of domestic F. catus were induced in order to scrutinize the antihyperlipidemic effects of local S. platensis LUQS1 strain, specifically at concentrations of 0.5 g/day and 1.0 g/day. Methodology and results: Elevation of serum lipid levels viz. total cholesterol (TC), high density lipoprotein (HDL), low density lipoprotein (LDL) and triglycerides (TG) as well as the status of kidney [creatinine (Cr) and blood urea nitrogen (BUN)] were observed in four groups of F. catus for 45 days. The highest levels for TC, LDL and TG (P < 0.05) were recorded in high cholesterol diet group (CD) at day 45 with 291.67±2.87 mg·dL⁻¹, 111.60±9.73 mg·dL⁻¹ and 146.33±10.44 mg·dL⁻¹, respectively. HDL levels in Spirulina-treated groups (CA and CAA) were better than normolipidemic group (control, SD group), of which the maximum levels were displayed at day 30 specifically 72.87±6.08 mg·dL⁻¹ by cats-fed with high cholesterol diet treated with 0.5 g/day S. platensis LUQS1 (CA group). There were insignificant differences (P > 0.05) in the BUN levels; however, the Cr levels in CAA group (day 30 and 45) were slightly out of normal range but did not classify under chronic condition. Conclusion, significance and impact of the study: Alternative treatments on hyperlipidemic cats were rarely reported by researchers and medicinal practitioners. Thus, the findings of this present study provided a genuine knowledge concerning the lipid-lowering effect of S. platensis LUQS1 on the hyperlipidemic cats.